Really, from our point of view, price was not a factor. As I mentioned earlier, we do have backup agreements in place with the Europeans and South Africans, and those agreements have set pricing in place.
We feel very strongly that we have an obligation to the health care system, and what we did was to proceed immediately to fulfill that obligation. So we contacted our suppliers, we contacted our customers, and we let everybody know that we needed as much medical isotope as they could supply us with to fill the gap. They stepped forward with what they could, but it was really insufficient.
Our business is to provide reliable suppl. It wasn't a price or business issue here.